Skip to Main Content

Paper Details

SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Nat Commun
113
2019
BRG1, CCND1, CDK4/6, NSCLC, NSCLCs, SMARCA2, SMARCA4, SMARCA4/2, SNF, SNF chromatin remodeling, SWI, SWI/, SWI/SNF chromatin remodeling gene, Tumor, c-Jun, cancers, cyclin D1, cyclin D1 deficiency, non-small cell lung cancer, ovarian cancer
Author NameAffiliation
Esther HerpelTissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, and Institute of Pathology, Heidelberg University Hospital
Sriram VennetiUniversity of Michigan Medical School ann arbor
Daniel MartinezChildren's Hospital of Philadelphia Research Institute
Daniel MartinezChildren's Hospital of Philadelphia Research Institute
Alexander R JudkinsChildren's Hospital Los Angeles, Keck School of Medicine of University of Southern California
Abbas AgaimyInstitute of Pathology, Friedrich-Alexander-University Erlangen-Nurnberg, University Hospital
William D FoulkesMcGill University
William D Foulkesand Lady Davis Institute, Jewish General Hospital, McGill University
William D FoulkesResearch Institute of the McGill University Health Centre, McGill University
William D FoulkesMcGill University
William D Foulkesand Lady Davis Institute, Jewish General Hospital, McGill University
William D FoulkesResearch Institute of the McGill University Health Centre, McGill University
  • 1 - 12

Datasets

Release 1.2